Syndeio Biosciences, Inc

This study tests whether a new oral drug called zelquistinel can reduce depression symptoms in adults with major depressive disorder. Participants take one tablet weekly for 6 weeks and have their depression severity checked at each clinic visit. The trial compares zelquistinel t…

This study tests an experimental drug called zelquistinel (GATE-251) to see if it can reduce symptoms of major depressive disorder. About 164 adults with depression will take either the drug or a placebo once a week for 6 weeks. Researchers will measure changes in depression scor…